448. Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns.
作者: Marie-Joelle Jabagi.;Marion Bertrand.;Amélie Gabet.;Epiphane Kolla.;Valérie Olié.;Mahmoud Zureik.
来源: JAMA. 2026年335卷9期787-798页
Respiratory syncytial virus (RSV) is a leading cause of hospitalization in infants. The comparative effectiveness of 2 recently introduced preventive strategies (infant immunization through placental antibody transfer after maternal vaccination with the RSV prefusion F protein [RSVpreF] vaccine and passive infant immunization with nirsevimab) remains unknown.
450. An mHealth (Mobile Health) Intervention for Smoking Cessation in People With Tuberculosis: A Cluster Randomized Clinical Trial.
作者: Maham Zahid.;Fahmidur Rahman.;Mahmoud Danaee.;Shakhawat Hossain Rana.;Asiful Chowdhury.;Saeed Ansaari.;Ai Keow Lim.;Melanie Boeckmann.;Steve Parrott.;Jinshuo Li.;Amina Khan.;Rumana Huque.;John Norrie.;Kamran Siddiqi.
来源: JAMA. 2026年335卷4期336-344页
Smoking worsens outcomes in people with tuberculosis (TB), while quitting hastens recovery.
|